Loading
A phase 3 trial of Epirubicin and Ethiodized oil in Hepatocellular carcinoma, run by Shanghai Zhongshan Hospital, with a status the registry has not verified recently.
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus is a phase 3 interventional study registered as NCT02971345 by Shanghai Zhongshan Hospital, with 253 participants planned, started 2017-01 and due to reach its primary completion in 2020-10. Interventions recorded: Stent and Iodine-125 seed strand implantation, Stent, Iodine-125 seed, Epirubicin, Ultra-fluid lipiodol, Gelatin sponge articles. Conditions recorded: Hepatocellular Carcinoma, Portal Vein Tumor Thrombus.
Linked to the drug Ethiodized oil because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.
Shares Ethiodized oil, Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Ethiodized oil, Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma and the tag pipeline.
Shares Hepatocellular carcinoma and the tag pipeline.
Shares Epirubicin and the tag pipeline.